Answers are grounded in this paper and cite their sources.
Evidence note explores MMP-9/TIMP-1 ratio’s role in barrier destabilization in multiple sclerosis, suggesting new biomarker potential.
This Evidence Note develops a Universal Resonance Model (URM) interpretation of the MMP-9/TIMP-1 ratio as a dynamic barrier destabilization signal in multiple sclerosis. It argues that the MMP-9/TIMP-1 ratio should not be interpreted only as a biomarker of inflammation, barrier injury, or static blood–brain barrier permeability. Instead, the ratio may reflect the balance between proteolytic destabilizing force and endogenous regulatory damping at the blood–brain barrier. Using the findings reported by Pavlovic et al. in Annals of Clinical and Translational Neurology (2025), this note interprets elevated CSF MMP-9/TIMP-1 ratio, association with gadolinium-enhancing lesions, longitudinal reduction after autologous hematopoietic stem cell transplantation, and predictive value for future disease activity as evidence consistent with dynamic barrier instability. The note distinguishes static permeability from dynamic instability and proposes that MMP-9/TIMP-1 may serve as a candidate ratio-based biomarker of barrier destabilization, residual instability, treatment response, and possible reset-related resilience restoration in immune-mediated CNS disease. This work is intended as a conceptual and evidence-based contribution to systems medicine, multiple sclerosis interpretation, and the URM framework.
No takes yet. Share an insight, caveat, or question.
Anita Domargård (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: